Formulation and Evaluation of Self Nano Emulsifying Drug Delivery System of Raloxifene Hydrochloride
Abstract
Raloxifene hydrochloride (RLX) is a selective Estrogen-receptor modulator used to treat osteoporosis as well as breast and endometrial cancer prevention. The bioavailability of RLX is only 2% due to substantial pre-systemic clearance. The goal of this research was to customise and characterise RLX-loaded self-nanoemulsifying drug-delivery systems (SNEDDS) by using bioactive excipients that impact drug metabolism. The droplet size, zeta potential and drug content determination of optimized formulation (F-06) was found to be 147.5 nm, -28.8, 99.67% respectively. The drug release study from the nano formulation was studied in Phosphate buffer 6.8 for all the formulations F1,F2,F3,F4,F5,F6 and F7. The optimized formulation was found to be F6
Keywords: Raloxifene hydrochloride, nanoemulsion, SNEDDSÂ
Keywords:
Raloxifene hydrochloride, nanoemulsion, SNEDDSDOI
https://doi.org/10.22270/jddt.v11i4.4857References
Jeevana JB, Sreelakshmi K. Design and evaluation of self-nanoemulsifying drug delivery system of flutamide. J Young Pharm. 2011; 3(1):4-8. https://doi.org/10.4103/0975-1483.76413
Elsheikh MA, Elnaggar YSR, Gohar EY, Abdallah OY. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: Optimization and in vivo appraisal. Int J Nanomedicine. 2012; 7: 3787-802. https://doi.org/10.2147/IJN.S33186
Patel J, Patel A, Raval M, Sheth N. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res. 2011; 2(1):9-16. https://doi.org/10.4103/2231-4040.79799
Balakumar K, Raghavan CV, selvan NT, prasad RH, Abdu S. Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surfaces B Biointerfaces [Internet]. 2013; 112:337-43. https://doi.org/10.1016/j.colsurfb.2013.08.025
Sakulku U, Nuchuchua O, Uawongyart N, Puttipipatkhachorn S, Soottitantawat A, Ruktanonchai U. Characterization and mosquito repellent activity of citronella oil nanoemulsion. Int J Pharm. 2009; 372(1-2):105-11. https://doi.org/10.1016/j.ijpharm.2008.12.029
Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007; 66(2):227-43. https://doi.org/10.1016/j.ejpb.2006.10.014
Zhao Y, Wang C, Chow AHL, Ren K, Gong T, Zhang Z, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int J Pharm. 2010; 383(1-2):170-7. https://doi.org/10.1016/j.ijpharm.2009.08.035
Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surfaces B Biointerfaces [Internet]. 2012; 100:50-61. https://doi.org/10.1016/j.colsurfb.2012.05.019
Tanya M. Smedds/Snedds: an Emerging Technique To Solubility Enhancement for the Pharmaceutical Industry. World J Pharm Pharm Sci. 2017; 6(7):317-36. https://doi.org/10.20959/wjpps20177-9493
Gupta P, Sharma PK, Kumar N, Pawar Y, Gupta J. Self nano emulsifying drug delivery system: a strategy to improve oral bioavailability. World J Pharm Pharm Sci [Internet]. 2014; 3(5):506-12, 7 pp. Available from: http://www.wjpps.com/admin/assets/article_issue/1399016390.pdf
Dash Tapaswi Rani, Sharma Pankaj, Sharma Sawati SP. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of lipophilic drugs. Indo Am J Pharm Res. 2017; 7(1):7361-8.
Savale SK. a Review - Self Nanoemulsifying Drug Delivery System (Snedds). Int J Res Pharm Nano Sci [Internet]. 2015; 4(6):385-97. Available from: http://www.ijrpns.com/article/A review - self nanoemulsifying drug delivery system (SNEDDS).pdf
Published
Abstract Display: 680 
PDF Downloads: 802 PDF Downloads: 181 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.